STRATEGIC NETWORKING DAY ON BIOSIMILARS 24th September 2015 Timings Schedule Leading Session 09.00 - 09.45 Registration Professor Stephen Chapman 09.45 - 10.00 Welcome Keele University Biosimilars view from APBI Biologic –The 10.00 10.30 TBC – Medicines Access Group Margaret Dolan Biosimilars The view from NHS – 10.30 - 11.00 procurement NHS Commercial Solutions How have organisations responded to Professor Ray Fitzpatrick Biosimilars for Filgrastim and Infliximab. 11.00 11.30 – Keele University Discussion in Groups Refreshment Break Professor Ray Fitzpatrick Feedback from Groups: What were the 11.45 12.15 – Issues/Challenges Keele University 12.15 12.45 Insulin Glargine its place in therapy Clinical Speaker TBC – Margaret Dolan 12.45 13.45 Biosimilar Insulin Glargine – NHS Commercial Solutions Lunch Professor Ray Fitzpatrick Glargine use in primary and secondary care 14.00 14.15 – in the West Midlands University Professor Ray Fitzpatrick Group Work Local Approach to Insulin 14.15 14.45 – Glargine Biosimilar Keele University Professor Ray Fitzpatrick 14.45 15.15 Feedback / Action Plans – Keele University Professor Ray Fitzpatrick Open for Chief Pharmacists and 15.15 - 15.45 HOMM’s Keele University Close
STRATEGIC NETWORKING DAY ON BIOSIMILARS 24th September 2015 Timings Schedule Leading Session 09.00 - 09.45 Registration 09.45 - 10.00 Welcome Professor Stephen Chapman Keele University 10.00 – 10.30 Biosimilars –The view from APBI Biologic Medicines Access Group TBC 10.30 - 11.00 Biosimilars – The view from NHS procurement Margaret Dolan NHS Commercial Solutions 11.00 – 11.30 How have organisations responded to Biosimilars for Filgrastim and Infliximab. Discussion in Groups Professor Ray Fitzpatrick Keele University Refreshment Break 11.45 – 12.15 Feedback from Groups: What were the Issues/Challenges Professor Ray Fitzpatrick Keele University 12.15 – 12.45 Insulin Glargine its place in therapy Clinical Speaker TBC 12.45 – 13.45 Biosimilar Insulin Glargine Margaret Dolan NHS Commercial Solutions Lunch 14.00 – 14.15 Glargine use in primary and secondary care in the West Midlands Professor Ray Fitzpatrick University 14.15 – 14.45 Group Work Local Approach to Insulin Glargine Biosimilar Professor Ray Fitzpatrick Keele University 14.45 – 15.15 Feedback / Action Plans Professor Ray Fitzpatrick Keele University 15.15 - 15.45 Open for Chief Pharmacists and HOMM’s Professor Ray Fitzpatrick Keele University Close
Stategic%20Network%20Day%20Agenda%2024-09-2015.docx